Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2015

Modulation of Retinal Neovascularization with Novel Related Transcriptional Enhancer Factor-1 (RTEF1 or TEAD4) Isoforms

Tawfik Issa; Matthew Hartzell; Tim Stout

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2315. doi:

ARVO Annual Meeting Abstract April 2014

NONCLINICAL DEVELOPMENT OF ENCORSTAT®, DONOR CORNEAL TISSUE GENETICALLY ENGINEERED TO PREVENT GRAFT REJECTION

Scott Ellis; Kyriacos Mitrophanous; Maria A Parker; Vicky Scripps; Trevor J McFarland; Matthew Hartzell; Binoy Appukuttan; Tim Stout

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3235. doi:

ARVO Annual Meeting Abstract June 2013

Assessment of Intravitreal AAV-TEAD4 Isoforms in the OIR Model

Matthew Hartzell; Andrew Stempel; Trevor McFarland; Binoy Appukuttan; Tim Stout

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2745. doi:

ARVO Annual Meeting Abstract March 2012

Ocular Derived Tead4 Isoforms Differentially Bind Yap1

Trevor J. Mcfarland; Matthew Hartzell; Andrew Stempel; Yuzhen Pan; Justine Smith; John T. Stout; Binoy Appukuttan

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1615. doi:

ARVO Annual Meeting Abstract March 2012

Evaluation Of AAV-DJ Vector As A Therapeutic Delivery System For Ocular Cells And Tissue

Matthew Hartzell; Maria Parker; Andrew Stempel; Trevor McFarland; Binoy Appukuttan; John T. Stout

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1895. doi:

Advertisement